SARCOMA,SOFT TISSUE
Clinical trials for SARCOMA,SOFT TISSUE explained in plain language.
Never miss a new study
Get alerted when new SARCOMA,SOFT TISSUE trials appear
Sign up with your email to follow new studies for SARCOMA,SOFT TISSUE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo attack on rare cancers: can immunotherapy boost radiation?
Disease control OngoingThis study is testing if adding a drug called atezolizumab (an immunotherapy) to the standard treatment of radiotherapy and surgery works better for soft tissue sarcoma. It will involve 62 adults with a type of sarcoma that can be removed by surgery. The main goal is to see if th…
Matched conditions: SARCOMA,SOFT TISSUE
Phase: PHASE2 • Sponsor: Centre Leon Berard • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
Scientists test new 'In-Situ' cancer vaccine strategy
Disease control OngoingThis early-stage trial is testing the safety of a new combination treatment for people with advanced cancers that have spread and cannot be removed by surgery. Doctors inject immune-stimulating drugs directly into a tumor, then give a small dose of radiation to that same spot. Th…
Matched conditions: SARCOMA,SOFT TISSUE
Phase: PHASE1 • Sponsor: University of Southern California • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
New combo attack on tough sarcomas before surgery
Disease control OngoingThis study is testing a new treatment approach for patients with certain soft tissue sarcomas. Before surgery, patients receive a combination of two immunotherapy drugs and a course of radiation therapy. The main goal is to see how much of the tumor is killed by this pre-surgery …
Matched conditions: SARCOMA,SOFT TISSUE
Phase: PHASE2 • Sponsor: Maria Sklodowska-Curie National Research Institute of Oncology • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
Scientists test Three-Pronged attack on aggressive sarcoma
Disease control OngoingThis early-stage trial is testing a new three-part treatment for people with intermediate or high-grade soft tissue sarcoma in the arms, legs, or trunk. Before surgery, participants receive a new drug called ADI-PEG 20 along with a standard chemotherapy (ifosfamide) and radiation…
Matched conditions: SARCOMA,SOFT TISSUE
Phase: PHASE1 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
Scientists test Two-Pronged attack on Tough-to-Treat sarcoma
Disease control OngoingThis small, early-stage study is testing whether it is safe and practical to combine a type of immunotherapy drug (pembrolizumab) with very precise, high-dose radiation (SBRT) for patients with advanced soft-tissue sarcoma. The goal is to see if this combination can help control …
Matched conditions: SARCOMA,SOFT TISSUE
Phase: EARLY_PHASE1 • Sponsor: University of California, Irvine • Aim: Disease control
Last updated Mar 23, 2026 15:16 UTC
-
New hope for Tough-to-Treat liposarcoma: Dual-Action drug trial
Disease control OngoingThis study is testing whether a combination of two immunotherapy drugs, etrumadenant and zimberelimab, can help control advanced dedifferentiated liposarcoma. It is for adults whose cancer has spread, returned after prior treatment, or cannot be removed by surgery. The main goal …
Matched conditions: SARCOMA,SOFT TISSUE
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Mar 23, 2026 15:14 UTC
-
Targeted drug trial offers hope for Tough-to-Treat sarcomas
Disease control OngoingThis study is testing whether the drug niraparib can help control advanced soft tissue or uterine sarcoma that has specific mutations in DNA repair genes. It is for adults whose cancer has worsened after at least one prior treatment. The main goals are to see if the drug can dela…
Matched conditions: SARCOMA,SOFT TISSUE
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Mar 20, 2026 14:47 UTC
-
Modified virus and radiation team up to shrink tough tumors before surgery
Disease control OngoingThis study is testing a two-part treatment for people with locally advanced soft tissue sarcomas, a type of cancer. Before surgery, patients receive a modified virus injected directly into the tumor along with standard radiation therapy. The goal is to see if this combination can…
Matched conditions: SARCOMA,SOFT TISSUE
Phase: PHASE2 • Sponsor: John Rieth • Aim: Disease control
Last updated Mar 16, 2026 15:25 UTC